The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Daratumumab Injection Market Research Report 2024
Synopsis
Market Analysis and Insights: Global Daratumumab Injection Market
The global Daratumumab Injection market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, 100 mg accounting for % of the Daratumumab Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Daratumumab Injection market size is valued at US$ million in 2021, while the North America and Europe Daratumumab Injection are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Daratumumab Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Daratumumab Injection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Daratumumab Injection market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Daratumumab Injection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Daratumumab Injection market.
Global Daratumumab Injection Scope and Market Size
Daratumumab Injection market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Daratumumab Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100 mg
400 mg
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Johnson & Johnson
Xi'an Janssen Pharmaceutical
Shanghai Henlius Biotech
Market Analysis and Insights: Global Daratumumab Injection Market
The global Daratumumab Injection market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, 100 mg accounting for % of the Daratumumab Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Daratumumab Injection market size is valued at US$ million in 2021, while the North America and Europe Daratumumab Injection are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Daratumumab Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Daratumumab Injection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Daratumumab Injection market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Daratumumab Injection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Daratumumab Injection market.
Global Daratumumab Injection Scope and Market Size
Daratumumab Injection market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Daratumumab Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100 mg
400 mg
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Johnson & Johnson
Xi'an Janssen Pharmaceutical
Shanghai Henlius Biotech
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Daratumumab Injection Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 100 mg
1.2.3 400 mg
1.3 Market by Application
1.3.1 Global Daratumumab Injection Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Daratumumab Injection Market Perspective (2017-2028)
2.2 Daratumumab Injection Growth Trends by Region
2.2.1 Daratumumab Injection Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Daratumumab Injection Historic Market Size by Region (2017-2022)
2.2.3 Daratumumab Injection Forecasted Market Size by Region (2023-2028)
2.3 Daratumumab Injection Market Dynamics
2.3.1 Daratumumab Injection Industry Trends
2.3.2 Daratumumab Injection Market Drivers
2.3.3 Daratumumab Injection Market Challenges
2.3.4 Daratumumab Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Daratumumab Injection Players by Revenue
3.1.1 Global Top Daratumumab Injection Players by Revenue (2017-2022)
3.1.2 Global Daratumumab Injection Revenue Market Share by Players (2017-2022)
3.2 Global Daratumumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Daratumumab Injection Revenue
3.4 Global Daratumumab Injection Market Concentration Ratio
3.4.1 Global Daratumumab Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Daratumumab Injection Revenue in 2021
3.5 Daratumumab Injection Key Players Head office and Area Served
3.6 Key Players Daratumumab Injection Product Solution and Service
3.7 Date of Enter into Daratumumab Injection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Daratumumab Injection Breakdown Data by Type
4.1 Global Daratumumab Injection Historic Market Size by Type (2017-2022)
4.2 Global Daratumumab Injection Forecasted Market Size by Type (2023-2028)
5 Daratumumab Injection Breakdown Data by Application
5.1 Global Daratumumab Injection Historic Market Size by Application (2017-2022)
5.2 Global Daratumumab Injection Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Daratumumab Injection Market Size (2017-2028)
6.2 North America Daratumumab Injection Market Size by Country (2017-2022)
6.3 North America Daratumumab Injection Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Daratumumab Injection Market Size (2017-2028)
7.2 Europe Daratumumab Injection Market Size by Country (2017-2022)
7.3 Europe Daratumumab Injection Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Daratumumab Injection Market Size (2017-2028)
8.2 Asia-Pacific Daratumumab Injection Market Size by Country (2017-2022)
8.3 Asia-Pacific Daratumumab Injection Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Daratumumab Injection Market Size (2017-2028)
9.2 Latin America Daratumumab Injection Market Size by Country (2017-2022)
9.3 Latin America Daratumumab Injection Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Daratumumab Injection Market Size (2017-2028)
10.2 Middle East & Africa Daratumumab Injection Market Size by Country (2017-2022)
10.3 Middle East & Africa Daratumumab Injection Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Daratumumab Injection Introduction
11.1.4 Johnson & Johnson Revenue in Daratumumab Injection Business (2017-2022)
11.1.5 Johnson & Johnson Recent Development
11.2 Xi'an Janssen Pharmaceutical
11.2.1 Xi'an Janssen Pharmaceutical Company Detail
11.2.2 Xi'an Janssen Pharmaceutical Business Overview
11.2.3 Xi'an Janssen Pharmaceutical Daratumumab Injection Introduction
11.2.4 Xi'an Janssen Pharmaceutical Revenue in Daratumumab Injection Business (2017-2022)
11.2.5 Xi'an Janssen Pharmaceutical Recent Development
11.3 Shanghai Henlius Biotech
11.3.1 Shanghai Henlius Biotech Company Detail
11.3.2 Shanghai Henlius Biotech Business Overview
11.3.3 Shanghai Henlius Biotech Daratumumab Injection Introduction
11.3.4 Shanghai Henlius Biotech Revenue in Daratumumab Injection Business (2017-2022)
11.3.5 Shanghai Henlius Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Daratumumab Injection Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of 100 mg
Table 3. Key Players of 400 mg
Table 4. Global Daratumumab Injection Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Daratumumab Injection Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Daratumumab Injection Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Daratumumab Injection Market Share by Region (2017-2022)
Table 8. Global Daratumumab Injection Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Daratumumab Injection Market Share by Region (2023-2028)
Table 10. Daratumumab Injection Market Trends
Table 11. Daratumumab Injection Market Drivers
Table 12. Daratumumab Injection Market Challenges
Table 13. Daratumumab Injection Market Restraints
Table 14. Global Daratumumab Injection Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Daratumumab Injection Market Share by Players (2017-2022)
Table 16. Global Top Daratumumab Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daratumumab Injection as of 2021)
Table 17. Ranking of Global Top Daratumumab Injection Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Daratumumab Injection Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Daratumumab Injection Product Solution and Service
Table 21. Date of Enter into Daratumumab Injection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Daratumumab Injection Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Daratumumab Injection Revenue Market Share by Type (2017-2022)
Table 25. Global Daratumumab Injection Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Daratumumab Injection Revenue Market Share by Type (2023-2028)
Table 27. Global Daratumumab Injection Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Daratumumab Injection Revenue Market Share by Application (2017-2022)
Table 29. Global Daratumumab Injection Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Daratumumab Injection Revenue Market Share by Application (2023-2028)
Table 31. North America Daratumumab Injection Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Daratumumab Injection Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Daratumumab Injection Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Daratumumab Injection Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Daratumumab Injection Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Daratumumab Injection Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Daratumumab Injection Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Daratumumab Injection Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Daratumumab Injection Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Daratumumab Injection Market Size by Country (2023-2028) & (US$ Million)
Table 41. Johnson & Johnson Company Detail
Table 42. Johnson & Johnson Business Overview
Table 43. Johnson & Johnson Daratumumab Injection Product
Table 44. Johnson & Johnson Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million)
Table 45. Johnson & Johnson Recent Development
Table 46. Xi'an Janssen Pharmaceutical Company Detail
Table 47. Xi'an Janssen Pharmaceutical Business Overview
Table 48. Xi'an Janssen Pharmaceutical Daratumumab Injection Product
Table 49. Xi'an Janssen Pharmaceutical Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million)
Table 50. Xi'an Janssen Pharmaceutical Recent Development
Table 51. Shanghai Henlius Biotech Company Detail
Table 52. Shanghai Henlius Biotech Business Overview
Table 53. Shanghai Henlius Biotech Daratumumab Injection Product
Table 54. Shanghai Henlius Biotech Revenue in Daratumumab Injection Business (2017-2022) & (US$ Million)
Table 55. Shanghai Henlius Biotech Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Daratumumab Injection Market Share by Type: 2021 VS 2028
Figure 2. 100 mg Features
Figure 3. 400 mg Features
Figure 4. Global Daratumumab Injection Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Daratumumab Injection Report Years Considered
Figure 9. Global Daratumumab Injection Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Daratumumab Injection Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Daratumumab Injection Market Share by Region: 2021 VS 2028
Figure 12. Global Daratumumab Injection Market Share by Players in 2021
Figure 13. Global Top Daratumumab Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daratumumab Injection as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Daratumumab Injection Revenue in 2021
Figure 15. North America Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Daratumumab Injection Market Share by Country (2017-2028)
Figure 17. United States Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Daratumumab Injection Market Share by Country (2017-2028)
Figure 21. Germany Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Daratumumab Injection Market Share by Region (2017-2028)
Figure 29. China Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Daratumumab Injection Market Share by Country (2017-2028)
Figure 37. Mexico Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Daratumumab Injection Market Share by Country (2017-2028)
Figure 41. Turkey Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Daratumumab Injection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Johnson & Johnson Revenue Growth Rate in Daratumumab Injection Business (2017-2022)
Figure 44. Xi'an Janssen Pharmaceutical Revenue Growth Rate in Daratumumab Injection Business (2017-2022)
Figure 45. Shanghai Henlius Biotech Revenue Growth Rate in Daratumumab Injection Business (2017-2022)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
